Mutual of America Capital Management LLC Decreases Stake in Medpace Holdings, Inc. (NASDAQ:MEDP)

Mutual of America Capital Management LLC lessened its holdings in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,462 shares of the company’s stock after selling 276 shares during the period. Mutual of America Capital Management LLC’s holdings in Medpace were worth $4,472,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of MEDP. State Street Corp grew its stake in shares of Medpace by 7.2% during the 3rd quarter. State Street Corp now owns 752,957 shares of the company’s stock worth $251,337,000 after purchasing an additional 50,312 shares during the period. Geode Capital Management LLC boosted its holdings in Medpace by 7.6% during the third quarter. Geode Capital Management LLC now owns 628,054 shares of the company’s stock worth $209,885,000 after buying an additional 44,371 shares in the last quarter. Wellington Management Group LLP grew its position in Medpace by 36.0% during the third quarter. Wellington Management Group LLP now owns 415,255 shares of the company’s stock worth $138,612,000 after buying an additional 109,886 shares during the period. American Capital Management Inc. increased its holdings in Medpace by 2.6% in the third quarter. American Capital Management Inc. now owns 380,646 shares of the company’s stock valued at $127,060,000 after buying an additional 9,592 shares in the last quarter. Finally, GW&K Investment Management LLC increased its holdings in Medpace by 93.9% in the fourth quarter. GW&K Investment Management LLC now owns 275,460 shares of the company’s stock valued at $91,516,000 after buying an additional 133,379 shares in the last quarter. Hedge funds and other institutional investors own 77.98% of the company’s stock.

Medpace Price Performance

NASDAQ:MEDP opened at $324.39 on Wednesday. Medpace Holdings, Inc. has a 1-year low of $302.01 and a 1-year high of $459.77. The firm has a 50 day simple moving average of $341.89 and a 200-day simple moving average of $344.26. The firm has a market cap of $9.88 billion, a PE ratio of 25.68, a P/E/G ratio of 3.81 and a beta of 1.36.

Medpace (NASDAQ:MEDP) last issued its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. As a group, sell-side analysts expect that Medpace Holdings, Inc. will post 12.29 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Robert W. Baird boosted their price target on Medpace from $354.00 to $362.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $381.44.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.